Esai Morales in Negotiations to Star in the Action Thriller “Shadow”

Esai Morales could be preparing for a little shadow play soon…

The 60-year-old Puerto Rican actor is in talks to star in the action thriller Shadow, which XYZ Films has boarded.

Esai MoralesXYZ acquired world sales — minus select territories — to the film, which is inspired by true events.

Colombian filmmaker Antonio Negret is directing from a screenplay he co-wrote with his brother Daniel Negret.

The film will begin production in the fall in Colombia.

The plot follows a real-life Colombian police dog named Sombra, who, after piling up hundreds of arrests, became the cartel’s public number one enemy. As a result, a bounty is put on her head. After the cartel’s new leader sets a trap to abduct the dog, Sombra’s once reluctant handler must risk his life and career to save his partner.

The cast features Colombian actors Juan Pablo Raba and Natalia Reyes alongside Kate Del Castillo.

Previously sold territories include Latin America (CDC), Brazil (CDC), Mexico (CDC), Russia (Volga), Middle East (Selim), Korea (Noori), and Indonesia (PT Amero).

“After having spent a great deal of time in Colombia, I became incredibly passionate about and committed to telling important and inspiring stories from a regional perspective with local stars like Juan Pablo & Natalia,” said Sentient president Renee Tab. “I’m looking forward to once again teaming up with long-term collaborators Pierre Morel, and Antonio Negret (as well as his brother Daniel) to shape this true story into an action narrative inspired by a drug-sniffing German Shepherd named Sombra.”

Morales’ previous credits include La Bamba, American Family, Resurrection Boulevard, Ozark and Titans.

Negret is best known for his debut film Towards Darkness, starring America Ferrera, which premiered in competition at Tribeca. His follow-ups Seconds Apart, a supernatural horror/thriller, was released by Lionsgate, and thriller Transit starring Jim Caviezel, was released by Silver Pictures/Dark Castle.

Leave a Reply